About this episode

Professor Thomas Powles discusses recent developments with circulating tumor DNA assays in the management of urothelial bladder cancer.

Professor Thomas Powles from Barts Cancer Institute in London, United Kingdom, discusses recent developments with circulating tumor DNA assays in the management of urothelial bladder cancer. CME information and select publications here .

People in this episode

Host: Dr. Neil Love

Guest: Professor Thomas Powles

Topics covered

• genitourinary cancers
• circulating tumor DNA
• urothelial bladder cancer
• tumor-informed assays
• cancer management

Keywords

• genitourinary cancers
• circulating tumor DNA
• urothelial bladder cancer
• assays
• cancer management

Mentioned in this episode

Organizations: Barts Cancer Institute

Places: London, United Kingdom

More episodes of Oncology Today with Dr Neil Love

• Genitourinary Cancers — 5-Minute Journal Club Issue 2 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays · June 5, 2026 · 23 min
• Antibody-Drug Conjugates in Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer · June 3, 2026 · 1h 31m
• Desmoid Tumors — Microlearning Activity 3 with Prof Bernd Kasper · June 2, 2026 · 23 min
• Colorectal Cancer — Year in Review Series on Relevant New Datasets and Advances · May 28, 2026 · 59 min
• Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances · May 23, 2026 · 59 min
• Ovarian Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer · May 21, 2026 · 1h 28m

Explore listener stats, chart rankings, contacts and more on the Oncology Today with Dr Neil Love podcast page.